Gilead Sciences Past Earnings Performance
Past criteria checks 1/6
Gilead Sciences has been growing earnings at an average annual rate of 2.4%, while the Biotechs industry saw earnings growing at 19.1% annually. Revenues have been growing at an average rate of 4.8% per year. Gilead Sciences's return on equity is 5.7%, and it has net margins of 3.8%.
Key information
2.4%
Earnings growth rate
2.8%
EPS growth rate
Biotechs Industry Growth | 17.0% |
Revenue growth rate | 4.8% |
Return on equity | 5.7% |
Net Margin | 3.8% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Gilead's New Anti-Obesity Drug: The Real Reason Behind The 25% Stock Surge?
Aug 05A Look At Gilead Sciences After Its Recent Weakness
Jul 27Gilead Records Positive Phase III Results In HIV
Jun 22Is Gilead Sciences (NASDAQ:GILD) Using Too Much Debt?
Jun 13Why Gilead Sciences' 4.6% Yield Doesn't Make The Cut For Smart Investors
May 23We Think Some Shareholders May Hesitate To Increase Gilead Sciences, Inc.'s (NASDAQ:GILD) CEO Compensation
May 02Gilead Sciences, Inc.'s (NASDAQ:GILD) P/E Is On The Mark
Apr 22Gilead Sciences: Some Signs Of An Impending Bottom
Apr 22Gilead Sciences: Realizing Financial Projections Is Key
Mar 20Gilead Sciences' (NASDAQ:GILD) Dividend Will Be Increased To $0.77
Mar 13Gilead's Business Development: The Good, The Bad, And The Spinning Kite Solution
Mar 01Gilead Sciences (NASDAQ:GILD) Has Announced That It Will Be Increasing Its Dividend To $0.77
Feb 28We Think Gilead Sciences' (NASDAQ:GILD) Solid Earnings Are Understated
Feb 15Gilead Sciences (NASDAQ:GILD) Is Increasing Its Dividend To $0.77
Feb 13Gilead Sciences: Cheap For A Reason
Feb 10Revenue & Expenses Breakdown
How Gilead Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 27,805 | 1,054 | 5,099 | 5,728 |
31 Mar 24 | 27,450 | 485 | 5,580 | 5,778 |
31 Dec 23 | 27,116 | 5,665 | 5,537 | 5,758 |
30 Sep 23 | 27,391 | 5,876 | 6,502 | 5,880 |
30 Jun 23 | 27,382 | 5,484 | 6,401 | 5,578 |
31 Mar 23 | 27,043 | 5,583 | 5,909 | 5,280 |
31 Dec 22 | 27,281 | 4,592 | 5,673 | 4,998 |
30 Sep 22 | 27,136 | 3,334 | 5,303 | 4,768 |
30 Jun 22 | 27,515 | 4,137 | 5,280 | 4,727 |
31 Mar 22 | 27,472 | 4,515 | 5,274 | 4,714 |
31 Dec 21 | 27,305 | 6,225 | 5,246 | 4,601 |
30 Sep 21 | 27,482 | 7,394 | 5,083 | 4,655 |
30 Jun 21 | 26,638 | 5,162 | 4,999 | 4,713 |
31 Mar 21 | 25,564 | 301 | 4,887 | 4,924 |
31 Dec 20 | 24,689 | 123 | 5,112 | 4,927 |
30 Sep 20 | 23,147 | 1,268 | 4,625 | 4,560 |
30 Jun 20 | 22,174 | -257 | 4,571 | 4,432 |
31 Mar 20 | 22,716 | 4,962 | 4,427 | 4,002 |
31 Dec 19 | 22,449 | 5,386 | 4,381 | 4,055 |
30 Sep 19 | 22,365 | 2,693 | 4,308 | 4,086 |
30 Jun 19 | 22,357 | 5,955 | 4,204 | 3,995 |
31 Mar 19 | 22,320 | 5,892 | 4,089 | 4,318 |
31 Dec 18 | 22,127 | 5,455 | 4,056 | 3,920 |
30 Sep 18 | 22,281 | 1,587 | 4,177 | 4,218 |
30 Jun 18 | 23,197 | 2,208 | 4,108 | 4,068 |
31 Mar 18 | 24,690 | 3,464 | 4,025 | 3,740 |
31 Dec 17 | 26,107 | 4,628 | 3,878 | 3,734 |
30 Sep 17 | 27,478 | 11,601 | 3,618 | 3,591 |
30 Jun 17 | 28,466 | 12,213 | 3,570 | 3,826 |
31 Mar 17 | 29,101 | 12,637 | 3,563 | 4,446 |
31 Dec 16 | 30,390 | 13,501 | 3,398 | 4,666 |
30 Sep 16 | 31,576 | 15,076 | 3,472 | 4,416 |
30 Jun 16 | 32,371 | 16,346 | 3,544 | 4,135 |
31 Mar 16 | 32,839 | 17,341 | 3,466 | 3,469 |
31 Dec 15 | 32,639 | 18,108 | 3,426 | 3,014 |
30 Sep 15 | 31,447 | 16,912 | 3,236 | 2,952 |
30 Jun 15 | 29,194 | 15,043 | 3,278 | 2,839 |
31 Mar 15 | 27,485 | 14,207 | 3,080 | 2,608 |
31 Dec 14 | 24,890 | 12,101 | 2,983 | 2,854 |
30 Sep 14 | 20,696 | 9,406 | 2,561 | 2,409 |
30 Jun 14 | 17,437 | 7,463 | 2,023 | 2,295 |
31 Mar 14 | 13,669 | 4,580 | 1,814 | 2,220 |
31 Dec 13 | 11,202 | 3,075 | 1,699 | 2,120 |
30 Sep 13 | 10,585 | 3,046 | 1,538 | 1,952 |
Quality Earnings: GILD has a large one-off loss of $8.5B impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: GILD's current net profit margins (3.8%) are lower than last year (20%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: GILD's earnings have grown by 2.4% per year over the past 5 years.
Accelerating Growth: GILD's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: GILD had negative earnings growth (-80.8%) over the past year, making it difficult to compare to the Biotechs industry average (0.5%).
Return on Equity
High ROE: GILD's Return on Equity (5.7%) is considered low.